Serotonin syndrome from combination hydrocodone and cyclobenzaprine in a patient with cerebral palsy

Vishal Bansal, Mayank Aranke, Peter Vu, Saba Javed

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: Serotonin syndrome (SS) is a life-threatening syndrome that occurs with the use of serotonergic drugs, most commonly due to two or more agents. Cerebral palsy is associated with mood disorders, and more commonly pain, with a prevalence of up to 50-80%. Case presentation: A 58-year-old female with cerebral palsy, metastatic malignancy and mood disorder who presented to the emergency department with acute-on-chronic pain, and signs of SS. She was initiated on iv. dilaudid, titrated off oral medications and scheduled for a left-sided sacroiliac joint injection. Results: It was suspected that due to additional doses of hydrocodone and cyclobenzaprine, she developed moderate-SS. Conclusion: Physicians need to be cognizant of comorbidities and uncommon pain medications that can predispose patients to SS.

Original languageEnglish (US)
Pages (from-to)329-334
Number of pages6
JournalPain management
Volume13
Issue number6
DOIs
StatePublished - Jun 1 2023

Keywords

  • cancer pain
  • cerebral palsy
  • chronic pain
  • cyclobenzaprine
  • hydrocodone
  • opioids
  • pain
  • serotonin syndrome

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Serotonin syndrome from combination hydrocodone and cyclobenzaprine in a patient with cerebral palsy'. Together they form a unique fingerprint.

Cite this